Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Stem Cells Translational Medicine
|
March 3, 2017
Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials
Archana Ramireddy, Chad R Brodt, Adam M Mendizabal, et al.
American Heart Journal
|
September 24, 2017
Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome
Sunjay Kaushal, Brody Wehman, Nicholas Pietris, et al.
Frontiers in Cell and Developmental Biology
|
June 25, 2021
The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases
Aisha Khan, Michael A Bellio, Ivonne H Schulman, et al.
Journal of the American College of Cardiology
|
October 31, 2015
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy
Vasileios Karantalis, Viky Y Suncion-Loescher, Luiza Bagno, et al.
Circulation Research
|
February 26, 2014
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial
Vasileios Karantalis, Darcy L DiFede, Gary Gerstenblith, et al.
Circulation Research
|
April 29, 2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit<sup>+</sup> Cardiac Stem Cells As Regenerative Therapy for Heart Failure)
Roberto Bolli, Joshua M Hare, Keith L March, et al.
JAMA
|
November 3, 2012
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial
Joshua M Hare, Joel E Fishman, Gary Gerstenblith, et al.
Circulation Research
|
January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial
Viky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
Samuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
October 5, 2017
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Bryon A Tompkins, Darcy L DiFede, Aisha Khan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Stem Cells Translational Medicine
|
March 3, 2017
Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials
Archana Ramireddy, Chad R Brodt, Adam M Mendizabal, et al.
American Heart Journal
|
September 24, 2017
Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome
Sunjay Kaushal, Brody Wehman, Nicholas Pietris, et al.
Frontiers in Cell and Developmental Biology
|
June 25, 2021
The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases
Aisha Khan, Michael A Bellio, Ivonne H Schulman, et al.
Journal of the American College of Cardiology
|
October 31, 2015
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy
Vasileios Karantalis, Viky Y Suncion-Loescher, Luiza Bagno, et al.
Circulation Research
|
February 26, 2014
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial
Vasileios Karantalis, Darcy L DiFede, Gary Gerstenblith, et al.
Circulation Research
|
April 29, 2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit<sup>+</sup> Cardiac Stem Cells As Regenerative Therapy for Heart Failure)
Roberto Bolli, Joshua M Hare, Keith L March, et al.
JAMA
|
November 3, 2012
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial
Joshua M Hare, Joel E Fishman, Gary Gerstenblith, et al.
Circulation Research
|
January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial
Viky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
Samuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
October 5, 2017
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Bryon A Tompkins, Darcy L DiFede, Aisha Khan, et al.
Page
of 3